$0.0740
-0.10-58.33%
Last update: Jun 23, 3:59 PM
Sangamo Therapeutics Inc
SGMOOTC
Sangamo Therapeutics fell 85.6% from $0.51 to $0.07, behind the S&P 500's +10.0%. Its worst day was Jun 23 (−57.5%), and its low came Jun 23 at $0.07.
Nov 10, 2025 – Jun 23, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Sangamo Therapeutics closed at its highest level of the year, 10.4% above where the year started.
+6.1% · S&P 500 +0.5%
EPS of $-0.11 missed the $-0.02 estimate on $14.2M revenue (est. $38.1M).
Story events cover the past 12 months · Times ET
−19.7% · S&P 500 +2.9%
Sangamo Therapeutics shares fell 37.3%, while the S&P 500 rose 0.8%.
−37.3% · S&P 500 +0.8%
EPS of $-0.08 missed the $-0.06 estimate on $1.4M revenue (est. $28.9M).
−0.4% · S&P 500 −1.2%
Where it ended: a close of $0.07 on Jun 23, 2026.
Nothing in the past 12 months.
All SGMO analyst actionsNothing in the past 12 months.
All SGMO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SGMO and SPY from Benzinga historical bars. Not investment advice.
